Treatment Registry
TR-0231 ActiveRecorded September 2026

Compounded semaglutide

Sold by Enhanced · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$249

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · 1 Month Supply · recorded initial monthly payment$249

Added from the figures recorded below.

Price

TermPublished rateCharged today
1 Month Supply

“1 Month Supply Save 10% $277/mo $249/mo”

Per month$249Charged today$249
3 Month Supply

“3 Month Supply Save 28% $277/mo $199/mo”

$199Published figureCharged todayNot verified
6 Month Supply

“6 Month Supply Best Value Save 35% $277/mo $179/mo”

$179Published figureCharged todayNot verified
Price sources
Visit Enhanced

We earn nothing from this link. It opens Enhanced's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
CancellationThe 90-Day Money-Back Guarantee applies only to eligible non-controlled prescription treatments offered through the Enhanced Performance Program and is available to new patients only.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from enhanced.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — Candidate list categorized Enhanced as 'Supplement,' but the site itself sells clinician-prescribed compounded semaglutide and tirzepatide under a 'WEIGHT RX' pathway alongside its no-script supplements, so it is in scope for this register (status ok, not not-glp1).

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0231
Medication category
compounded semaglutide
Readings
1

Related records

Other records from Enhanced

All Enhanced programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 372 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Enhanced — compounded semaglutide (TR-0231). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0231

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.